Immunogenicity and Safety of DTP-HB-Hib Using New Hepatitis B Bulk (Bio Farma)
Conditions: Diphtheria Vaccine Adverse Reaction; Tetanus Vaccine Adverse Reaction; Pertussis Vaccine Adverse Reaction; Haemophilus Influenzae Type B Vaccine Adverse Reaction; Hepatitis B Vaccine Adverse Reaction Interventions: Biological: Recombinant Hepatitis B new Bulk vaccine; Biological: DTP-HB-Hib with Recombinant Hepatitis B new Bulk vaccine; Biological: Recombinant Hepatitis B vaccine (Registered BioFarma); Biological: Pentabio Sponsors: PT Bio Farma; Hasan Sadikin General Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Haemophilus Influenzae (Hib) | Hepatitis | Hepatitis B | Hepatitis Vaccine | Hospitals | Influenza Vaccine | Research | Vaccines